Turnstone Biologics Corp Sustainability Reports
Turnstone Biologics Corp focuses on developing innovative immunotherapies for cancer treatment using oncolytic viruses and tumor-infiltrating lymphocytes.
Sector: Health Care
Country: United States
Exchange: Nasdaq Stock Market
ISIN: US90042W1009
1 reports from 2023 to 2023
Company Profile
Turnstone Biologics Corp
Turnstone Biologics Corp focuses on developing innovative immunotherapies for cancer treatment using oncolytic viruses and tumor-infiltrating lymphocytes.
Reports